Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/2007
07/03/2007US7238818 Heterocyclic metallocenes and polymerization catalysts
07/03/2007US7238815 Reacting a dimethyl 3-oxoglutarate with malononitrile in methanol in presence of morpholine to form an intermediate, reacting intermediate with sulfur, heating and isolating 5-amino-3-carboxymethyl-4-cyano-2-thiophene caroxylic acid
07/03/2007US7238811 Chemical compounds
07/03/2007US7238725 Tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
07/03/2007US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis.
07/03/2007US7238713 Muscarinic agonists
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007CA2219655C Process for the catalytic hydrogenation of aromatic nitro compounds
06/2007
06/28/2007WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives
06/28/2007WO2007071766A2 Phenoxy acetic acids as ppar delta activators
06/28/2007WO2007071609A1 Malononitrile compounds
06/28/2007WO2007071441A1 Inhibitors of ccr9 activity
06/28/2007WO2007071440A1 Inhibitors of ccr9 activity
06/28/2007WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
06/28/2007US20070149810 Vitamin d receptor modulators
06/28/2007US20070149787 Process for producing 2-acylthiophene compound
06/28/2007US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives
06/28/2007US20070149522 Method for producing 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
06/28/2007US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide
06/28/2007CA2634601A1 Malononitrile compounds
06/28/2007CA2632438A1 Inhibitors of ccr9 activity
06/28/2007CA2631432A1 Inhibitors of ccr9 activity
06/28/2007CA2631390A1 Phenoxy acetic acids as ppar delta activators
06/27/2007EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
06/27/2007EP1799658A2 Modulators of crth2 rezeptor activity for the treatment of prostaglandin d2 mediated diseases
06/27/2007EP1799636A2 Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives
06/27/2007EP1799627A1 Iron or cobalt-catalyzed carbon-carbon coupling reaction of aryls, alkenes and alkines with copper reagents
06/27/2007EP1480955B1 O-cyclopropyl-carboxanilides and their use as fungicides
06/27/2007CN1989115A Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
06/27/2007CN1986603A Two-dimensional conjugated polymer and its preparing method and application
06/26/2007US7235664 Potassium channel modulators; antiarrhythmia agents
06/26/2007US7235343 Photoacid generators, chemically amplified resist compositions, and patterning process
06/21/2007WO2007069569A1 Organic electroluminescence element material and organic electroluminescence element using same
06/21/2007WO2007068929A1 Cyclic amine derivatives and their uses
06/21/2007WO2007068377A1 Carboxamides for controlling micro-organisms in plant and material protection
06/21/2007WO2007068373A1 Carboxamides
06/21/2007WO2007068330A1 2-ADAMANTYLUREA DERIVATIVES AS SELECTIVE 11β-HSD1 INHIBITORS
06/21/2007WO2007047447A3 Diuretic-like compound analogs useful for regulation of central nervous system disorders
06/21/2007WO2007030567A3 Pparactive compounds
06/21/2007US20070142649 Preparation of heterocyclic ketones
06/21/2007US20070142476 Biphenyl-Derivatives as p38 Kinase Inhibitors
06/21/2007US20070142445 4-(3,3-Dihalo-Allyloxy) Phenoxy Alkyl Derivatives
06/21/2007US20070142443 Asymmetric reductive amination of keto acid derivatives for producing amino acid derivatives
06/21/2007US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/21/2007US20070142381 Calcium receptor modulating agents
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/21/2007US20070142335 e.g. 2-amino-2-methyl-4-{1-methyl-5-[4-(3,4-dimethylphenyl)butanoyl]pyrrol-2-yl}butan-1-ol ; immunology-related disease selected from crohn's disease ulcerative colitis, multiple sclerosis, atopic dermatitis, insulin dependent diabetes mellitus, glomerular nephritis and rejection of a transplanted organ
06/21/2007US20070142333 Cycloalkyl inhibitors of potassium channel function
06/21/2007US20070142230 herbicides; act against broad-leaved weeds and grass weeds in crops such as wheat, rice, corn, soya and cotton without causing any significant damage to the crop plants
06/21/2007US20070142229 Agriculture
06/21/2007DE102005060468A1 Thienylpyridylcarboxamide Thienylpyridylcarboxamide
06/21/2007CA2633192A1 Carboxamides for controlling micro-organisms in plant and material protection
06/21/2007CA2633186A1 2-adamantylurea derivatives as selective 11.beta.-hsd1 inhibitors
06/20/2007EP1797100A1 Nitrate esters and their use for mitigating cellular damage
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007EP1797064A1 Novel compounds useful for modulating abnormal cell proliferation
06/20/2007EP1797063A1 Use of 3-substituted thiophenes as odorants and flavourings
06/20/2007EP1575961B1 Method for the decarboxylation of dicarboxylic acids
06/20/2007EP1381590B1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands
06/20/2007EP1366043B1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
06/20/2007CN1984899A CXCR1 and CXCR2 chemokine antagonists
06/20/2007CN1984897A Light-emitting device material and light-emitting device
06/20/2007CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/20/2007CN1982290A Fungicidal carboxamides
06/20/2007CN1321964C Lightfast additive having uv-absorbing moiety and ink composition including the same
06/19/2007US7232811 Furosemide modulators of HM74
06/19/2007US7232616 Complex
06/14/2007WO2007067817A1 Abca1 elevating compounds
06/14/2007WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors
06/14/2007WO2006051397A8 Oligonucleotide probes
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/14/2007US20070135497 Biphenyl derivative or its salt, and pesticide containing it as an active ingredient
06/14/2007US20070135496 Substituted benzylaminoalkylene heterocycles
06/14/2007US20070135486 antidiabetic drugs or foods; sulfonium compounds
06/14/2007CA2632212A1 Plasminogen activator inhibitor-1 inhibitors
06/13/2007EP1795206A1 Drug for treating or preventing hcv infection
06/13/2007EP1794143A1 Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
06/13/2007EP1794117A2 Mercaptoamides as histone deacetylase inhibitors
06/13/2007EP1214292B1 Tyrosine derivatives
06/13/2007CN1980920A Thiophene derivatives, their manufacture and use as pharmaceutical agents
06/13/2007CN1978439A Star-shaped oligothiophene-arylene derivatives and organic thin film transistors using the same
06/13/2007CN1321115C Piperazine derivatives for use as CCR-3 receptor antagonists in the treatment of asthma
06/13/2007CN1321101C New retinoids for the treatment of emphysema
06/12/2007US7230121 For addition polymers; photopolymerization
06/12/2007US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer
06/12/2007US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
06/12/2007US7229994 Analgesics; anxiolytic agents; gastrointestinal disorders
06/12/2007US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
06/12/2007US7229987 Oxazoles with one or more tertiary amine groups and phenyl groups, e.g., 1-{4-[2-(Benzofuran-2-ylmethoxymethyl)-oxazol-5-yl]-phenyl}-3-(2-dimethylamino-ethyl)-urea and -(3-{4-[2-(2-Phenoxy-ethylsulfanylmethyl)-oxazol-5-yl]-phenoxy}-propyl)-azepine; treating obesity and related diseases, e.g., diabetes
06/12/2007US7229702 9,9-Dimethylfluorene trimers capped with N-(9-anthracenyl- or 9-phenanthrenyl)-N-p-tolylamine used to produce an organic light-emitting device that exhibits an extremely pure luminescent hue and has a light emission of high efficiency, high brightness, and long lifetime
06/12/2007CA2354023C Phenylglycine derivatives
06/12/2007CA2239569C Improved metal-ligand complex catalyzed processes
06/07/2007WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases
06/07/2007WO2007063086A1 Novel nk1 and nk2 antagonists
06/07/2007WO2007062996A1 3-amino-1-arylpropyl indoles and aza-substituted indoles
06/07/2007WO2007038253A3 Dnt-maleate and methods of preparation thereof
06/07/2007WO2007024744A3 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
06/07/2007WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 329